Naringenin - a potential nephroprotective agent for diabetic kidney disease: A comprehensive review of scientific evidence

• Published in: Biomolecules & biomedicine Vol. 24; no. 6; pp. 1441 - 1451
• Main Authors: Valle-Velázquez, Estefania, Zambrano-Vásquez, Oscar René, Cortés-Camacho, Fernando, Sánchez-Lozada, Laura Gabriela, Guevara-Balcázar, Gustavo, Osorio-Alonso, Horacio
• Format: Journal Article
• Language: English
• Published: Bosnia and Herzegovina Association of Basic Medical Sciences of Federation of Bosnia and Herzegovina 17-10-2024
• Subjects: Animals; Anti-Inflammatory Agents - pharmacology; Anti-Inflammatory Agents - therapeutic use; Antioxidants - pharmacology; Antioxidants - therapeutic use; chronic kidney disease (CKD); Diabetes; Diabetic Nephropathies - drug therapy; Flavanones - pharmacology; Flavanones - therapeutic use; Humans; hypertension; inflammation; naringenin; oxidative stress; Oxidative Stress - drug effects; Protective Agents - pharmacology; Protective Agents - therapeutic use; Renal Insufficiency, Chronic - drug therapy
• ISSN: 2831-0896; 2831-090X; 2831-090X
• DOI: 10.17305/bb.2024.10511

Diabetes mellitus (DM) is a chronic disease characterized by persistent hyperglycemia, which is a major contributing factor to chronic kidney disease (CKD), end-stage renal disease (ESRD), and cardiovascular-related deaths. There are several mechanisms leading to kidney injury, with hyperglycemia well known to stimulate oxidative stress, inflammation, tissue remodeling, and dysfunction in the vascular system and organs. Increased reactive oxygen species (ROS) decrease the bioavailability of vasodilators while increasing vasoconstrictors, resulting in an imbalance in vascular tone and the development of hypertension. Treatments for diabetes focus on controlling blood glucose levels, but due to the complexity of the disease, multiple drugs are often required to successfully delay the development of microvascular complications, including CKD. In this context, naringenin, a flavonoid found in citrus fruits, has demonstrated anti-inflammatory, anti-fibrotic, and antioxidant effects, suggesting its potential to protect the kidney from deleterious effects of diabetes. This review aims to summarize the scientific evidence of the effects of naringenin as a potential therapeutic option for diabetes-induced CKD.